<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age/><report-id>PHHY2012JP107191</report-id><gender>male</gender><reactions><reaction>Membranous stenosis/ concentric stenosis formed from the end of the ileum</reaction><reaction>Intestinal obstruction/ obstructive ileus</reaction><reaction>Intestinal dilatation</reaction><reaction>Fluid retention</reaction><reaction>Abdominal distension</reaction><reaction>High density matter of 10 mm in size from the ileocecal region about 20 cm to the end of ileum</reaction><reaction>Annular ulcer / circumferential ring-form ulcer</reaction><reaction>Epigastric pain</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>DICLOFENAC</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Pain management</indication></indications><outcomes><outcome>Required Inpatient Hospitalization</outcome></outcomes><country>Japan</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4053154_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20121211134142</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>2</safetyreportversion>
		<safetyreportid>PHHY2012JP107191</safetyreportid>
		<primarysourcecountry>JP</primarysourcecountry>
		<occurcountry>JP</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2012-12-11</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2012-11-19</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2012-12-05</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHY2012JP107191</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reportergivename>Mitsuru</reportergivename>
			<reporterfamilyname>Esaki</reporterfamilyname>
			<reporterorganization>Saiseikai Fukuoka General Hospital</reporterorganization>
			<reporterdepartment>Department of Internal Medicine</reporterdepartment>
			<reporterstreet>Fukuoka Prefecture</reporterstreet>
			<reportercountry>JP</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
			<literaturereference>Esaki M, Ochiai T, Mukai K,  Ikeda H, Nishijima K, Tomita Y, et al.,. A case of NSAID-induced membranous stenosis of the small intestine diagnosed from intestinal obstruction due to incarceration of a seed. The 100th Kyushu regional meeting of The Japanese Society of Gastroenterology. 2012;199</literaturereference>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>--</patientinitial>
			<patientagegroup>6</patientagegroup>
			<patientsex code="1">Male</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Bladder cancer</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Gastric operation</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Membranous stenosis/ concentric stenosis formed from the end of the ileum</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Gastrointestinal stenosis</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Gastrointestinal stenosis</reactionmeddrapt>
				<reactionstartdateformat>610</reactionstartdateformat>
				<reactionstartdate>201108</reactionstartdate>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Intestinal obstruction/ obstructive ileus</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Intestinal obstruction</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Intestinal obstruction</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Intestinal dilatation</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Intestinal dilatation</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Intestinal dilatation</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Fluid retention</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Fluid retention</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Fluid retention</reactionmeddrapt>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Abdominal distension</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Abdominal distension</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Abdominal distension</reactionmeddrapt>
				<reactionstartdateformat>610</reactionstartdateformat>
				<reactionstartdate>201108</reactionstartdate>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>High density matter of 10 mm in size from the ileocecal region about 20 cm to the end of ileum</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Intestinal mass</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Intestinal mass</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Annular ulcer / circumferential ring-form ulcer</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Gastrointestinal ulcer</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Gastrointestinal ulcer</reactionmeddrapt>
				<reactionstartdateformat>610</reactionstartdateformat>
				<reactionstartdate>201108</reactionstartdate>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Epigastric pain</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Epigastric pain</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Abdominal pain upper</reactionmeddrapt>
				<reactionstartdateformat>610</reactionstartdateformat>
				<reactionstartdate>201108</reactionstartdate>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<test>
				<testname>Computerised tomogram</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testname>Endoscopy gastrointestinal</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testname>X-ray</testname>
				<moreinformation>1</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>DICLOFENAC</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationnumb>19-201</drugauthorizationnumb>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>75</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>75 mg, QD</drugdosagetext>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Pain management</drugindication>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>DICLOFENAC</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal distension</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal distension</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain upper</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal pain upper</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Fluid retention</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Fluid retention</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal stenosis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal stenosis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal ulcer</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal ulcer</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Intestinal dilatation</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Intestinal dilatation</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Intestinal mass</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Intestinal mass</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Intestinal obstruction</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Intestinal obstruction</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHY2012JP107191, is an <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">initial </Semaphore>literature report received on 19 Nov 2012 with a follow up report received on 05 Dec 2012. The author discuss about “A case of NSAID induced <Semaphore x="2215861" class="AnatomicStructure" value="Membrane" score="1.00" ID="C12749">membranous </Semaphore><Semaphore x="3253414" class="MedDRA LLT" value="Small intestinal stenosis" score="1.00" ID="10062263"><Semaphore x="2352492" class="Disease or Finding" value="Other Finding" score="0.58" ID="C36295">stenosis </Semaphore>of the <Semaphore x="1968237" class="AnatomicStructure" value="Gastrointestinal System Part" score="0.58" ID="C25763">small <Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">intestine </Semaphore></Semaphore></Semaphore><Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore>from <Semaphore x="1623343" class="Procedure" value="Bowel Obstruction Management" score="1.00" ID="C51995">intestinal obstruction </Semaphore>due to <Semaphore x="3029964" class="MedDRA LLT" value="Imprisonment" score="1.00" ID="10021554">incarceration </Semaphore>of a <Semaphore x="2503835" class="Procedure" value="Seed Implantation" score="1.00" ID="C16219">seed</Semaphore>”. This report refers to an <Semaphore x="2923190" class="MedDRA LLT" value="Elderly" score="1.00" ID="10014348">elderly </Semaphore>(70 to <Semaphore x="1387834" class="Patient Age" value="79" score="1.00" ID=""><Semaphore x="5960701642276865" class="Patient Age" value="79" score="1.00" ID="">79</Semaphore>)-year old </Semaphore>male patient. The patient received <Semaphore x="465077" class="Medicine" value="Diclofenac Sodium" score="0.74" ID="241510">diclofenac <Semaphore x="2536895" class="Procedure" value="Sodium Measurement" score="1.00" ID="C64809">sodium </Semaphore></Semaphore>(<Semaphore x="2199623" class="Occupation" value="Manufacturer" score="1.00" ID="C25392">manufacturer </Semaphore>unknown) on an unknown date at a dose of 75 mg daily <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">orally </Semaphore>for <Semaphore x="3167117" class="MedDRA LLT" value="Pain" score="1.00" ID="10033371">pain </Semaphore><Semaphore x="1854518" class="Disease or Finding" value="Disease Controlled" score="1.00" ID="C82500">control </Semaphore>due to <Semaphore x="1595965" class="Disease or Finding" value="Bladder Cancer cM0 TNM Finding v7" score="1.00" ID="C89364">bladder cancer </Semaphore>since 3 years before. On an unknown date, the patient experienced <Semaphore x="1405486" class="Disease or Finding" value="Abdominal Distention" score="1.00" ID="C78161">abdominal <Semaphore x="2706105" class="MedDRA LLT" value="Abdominal distension" score="1.00" ID="10000060">distension </Semaphore></Semaphore>and <Semaphore x="2706678" class="MedDRA LLT" value="Abdominal pain upper" score="1.00" ID="10000087">epigastric <Semaphore x="2365183" class="Disease or Finding" value="Pain" score="1.00" ID="C3303">pain</Semaphore></Semaphore>. The symptoms became aggravated and the patient was admitted to our hospital for close examination and medical <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment</Semaphore>. <Semaphore x="1405836" class="Procedure" value="Abdominal Radiography" score="1.00" ID="C38102">Abdominal plain X ray </Semaphore>showed a <Semaphore x="2954820" class="MedDRA LLT" value="Flatulence" score="1.00" ID="10016766">gas </Semaphore>pattern in the <Semaphore x="1968237" class="AnatomicStructure" value="Gastrointestinal System Part" score="0.58" ID="C25763">small <Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">intestine </Semaphore></Semaphore>associated with a horizontal picture. <Semaphore x="1762050" class="AnatomicStructure" value="Chest" score="1.00" ID="C25389">Chest </Semaphore>plain <Semaphore x="2871950" class="MedDRA LLT" value="Computerised tomogram" score="1.00" ID="10010234">CT <Semaphore x="2444079" class="Procedure" value="Radionuclide Imaging" score="1.00" ID="C62667">scanning </Semaphore></Semaphore>showed <Semaphore x="3046048" class="MedDRA LLT" value="Intestinal dilatation" score="1.00" ID="10022642">intestinal <Semaphore x="1852850" class="Disease or Finding" value="Dilation" score="1.00" ID="C113136">dilatation</Semaphore></Semaphore>, <Semaphore x="2955345" class="MedDRA LLT" value="Fluid retention" score="1.00" ID="10016807">fluid retention </Semaphore>and a high density matter of 10 <Semaphore x="2239010" class="Disease or Finding" value="Morular Metaplasia of the Endometrium" score="1.00" ID="C37269">mm </Semaphore>in size from the ileocecal region about 20 cm to the <Semaphore x="1883294" class="Procedure" value="End-of-Life Treatment Management" score="1.00" ID="C67359">end </Semaphore>of <Semaphore x="1968237" class="AnatomicStructure" value="Gastrointestinal System Part" score="0.58" ID="C25763">ileum</Semaphore>. <Semaphore x="2328669" class="Disease or Finding" value="Obstruction" score="1.00" ID="C3284">Obstruction </Semaphore>in the region was suspected and the patient received conservative <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy </Semaphore>with <Semaphore x="2949378" class="MedDRA LLT" value="Fasting" score="1.00" ID="10068315">fasting </Semaphore>and fluid <Semaphore x="1607470" class="Procedure" value="Blood Transfusion" score="1.00" ID="C15192">transfusion</Semaphore>. On hospital day 3, defecation was observed and <Semaphore x="2707150" class="MedDRA LLT" value="Abdominal symptom" score="1.00" ID="10060926">abdominal symptoms </Semaphore>improved. On hospital day 5, lower <Semaphore x="1965448" class="Procedure" value="Gastrointestinal Endoscopy" score="1.00" ID="C78162">gastrointestinal endoscopy </Semaphore>was performed for close examination in the <Semaphore x="1883294" class="Procedure" value="End-of-Life Treatment Management" score="1.00" ID="C67359">end </Semaphore>of the <Semaphore x="1968237" class="AnatomicStructure" value="Gastrointestinal System Part" score="0.58" ID="C25763">ileum</Semaphore>. A <Semaphore x="1782977" class="Disease or Finding" value="Circumferential Endothelial Hyperplasia" score="1.00" ID="C96346">circumferential </Semaphore>ring form <Semaphore x="2660939" class="Disease or Finding" value="Ulcerated Oral Leukoplakia" score="1.00" ID="C4694">ulcer </Semaphore>and concentric <Semaphore x="2352492" class="Disease or Finding" value="Other Finding" score="0.58" ID="C36295">stenosis </Semaphore>formed from the <Semaphore x="1883294" class="Procedure" value="End-of-Life Treatment Management" score="1.00" ID="C67359">end </Semaphore>of the <Semaphore x="1968237" class="AnatomicStructure" value="Gastrointestinal System Part" score="0.58" ID="C25763">ileum </Semaphore>about 20 cm to the <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">mouth </Semaphore>side. The <Semaphore x="2107425" class="Disease or Finding" value="Lesion" score="1.00" ID="C3824">lesion </Semaphore>was considered as NSAID induced. Contrast enhanced <Semaphore x="1846529" class="Procedure" value="Diagnostic Procedure" score="0.58" ID="C18020">imaging </Semaphore>using gastrografin of the <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">mouth </Semaphore>side stenotic region showed concentric <Semaphore x="2352492" class="Disease or Finding" value="Other Finding" score="0.58" ID="C36295">stenosis </Semaphore>at 4 sites within the range of about 30 cm. At the time, a mobile spherical translucency pattern of 10 <Semaphore x="2239010" class="Disease or Finding" value="Morular Metaplasia of the Endometrium" score="1.00" ID="C37269">mm </Semaphore>in size was observed in the <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">mouth </Semaphore>side of the stenotic region. On hospital day 17, trans <Semaphore x="1534023" class="AnatomicStructure" value="Anus" score="1.00" ID="C43362">anal </Semaphore>double balloon <Semaphore x="2931854" class="MedDRA LLT" value="Endoscopy" score="1.00" ID="10014805">endoscopy </Semaphore>was performed and balloon <Semaphore x="1852850" class="Disease or Finding" value="Dilation" score="1.00" ID="C113136">dilatation </Semaphore>was given to 2 sites of rig form <Semaphore x="2660939" class="Disease or Finding" value="Ulcerated Oral Leukoplakia" score="1.00" ID="C4694">ulcer </Semaphore>and <Semaphore x="2215861" class="AnatomicStructure" value="Membrane" score="1.00" ID="C12749">membranous </Semaphore><Semaphore x="2352492" class="Disease or Finding" value="Other Finding" score="0.58" ID="C36295">stenosis </Semaphore>observed at many sites in the <Semaphore x="1883294" class="Procedure" value="End-of-Life Treatment Management" score="1.00" ID="C67359">end </Semaphore>of the <Semaphore x="1968237" class="AnatomicStructure" value="Gastrointestinal System Part" score="0.58" ID="C25763">ileum </Semaphore>on Aug 2012. After balloon <Semaphore x="1852850" class="Disease or Finding" value="Dilation" score="1.00" ID="C113136">dilatation</Semaphore>, a hard <Semaphore x="2539154" class="Disease or Finding" value="Solid Glomus Tumor" score="1.00" ID="C51133">solid </Semaphore>incarcerated in the stenotic region was collected, and <Semaphore x="2596409" class="Procedure" value="Surgical Procedure" score="1.00" ID="C15329">operation </Semaphore>was finished. The <Semaphore x="2201019" class="Disease or Finding" value="Mass" score="1.00" ID="C34808">mass </Semaphore>was found to be a <Semaphore x="2503835" class="Procedure" value="Seed Implantation" score="1.00" ID="C16219">seed </Semaphore>of umeboshi. The patient followed a favorable postoperative course and was discharged from our hospital at 6 days after <Semaphore x="2596409" class="Procedure" value="Surgical Procedure" score="1.00" ID="C15329">operation</Semaphore>. The author experienced a case of obstructive <Semaphore x="2044010" class="Disease or Finding" value="Ileus" score="1.00" ID="C37979">ileus </Semaphore>caused by <Semaphore x="3029964" class="MedDRA LLT" value="Imprisonment" score="1.00" ID="10021554">incarceration </Semaphore>of an intestinal transit matter (<Semaphore x="2503835" class="Procedure" value="Seed Implantation" score="1.00" ID="C16219">seed</Semaphore>) in the <Semaphore x="2215861" class="AnatomicStructure" value="Membrane" score="1.00" ID="C12749">membranous </Semaphore>stenotic region in the <Semaphore x="1883294" class="Procedure" value="End-of-Life Treatment Management" score="1.00" ID="C67359">end </Semaphore>of the <Semaphore x="1968237" class="AnatomicStructure" value="Gastrointestinal System Part" score="0.58" ID="C25763">ileum </Semaphore>formed by long term NSAID administration. The <Semaphore x="2352492" class="Disease or Finding" value="Other Finding" score="0.58" ID="C36295">outcome </Semaphore>of <Semaphore x="2973927" class="MedDRA LLT" value="Gastrointestinal stenosis" score="1.00" ID="10018007"><Semaphore x="2584843" class="Disease or Finding" value="Stenosis" score="1.00" ID="C50754"><Semaphore x="1968362" class="Disease or Finding" value="Gastrointestinal System Stenosis" score="1.00" ID="C79468">gastrointestinal <Semaphore x="1968362" class="Disease or Finding" value="Gastrointestinal System Stenosis" score="1.00" ID="C79468">stenosis </Semaphore>and for <Semaphore x="2974315" class="MedDRA LLT" value="Gastrointestinal ulcer" score="1.00" ID="10061459">gastrointestinal </Semaphore></Semaphore>
      </Semaphore>
     </Semaphore>
    <Semaphore x="2660939" class="Disease or Finding" value="Ulcerated Oral Leukoplakia" score="1.00" ID="C4694">ulcer </Semaphore>was reported as condition improving and for the other event was not reported. The causality for the events was reported as suspected with <Semaphore x="465077" class="Medicine" value="Diclofenac Sodium" score="0.74" ID="241510">diclofenac <Semaphore x="2536895" class="Procedure" value="Sodium Measurement" score="1.00" ID="C64809">sodium</Semaphore></Semaphore>.Follow up report received on 05 Dec 2012: Updated reporter details, events, clinical course seriousness and <Semaphore x="2352492" class="Disease or Finding" value="Other Finding" score="0.58" ID="C36295">outcome</Semaphore>.</narrativeincludeclinical>
				<sendercomment>MAC : 
Based on review of available reported data there is a reasonable possibility of causal relationship for the events.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>